Senior Researcher @The Public Health Service of Amsterdam &
The University of Amsterdam, department of Social Psychology &
Vice chair of AFEW International
🧵1/6 Welcome to Day 3 of our #COVID19-themed week on Twitter!🤓 Today we're highlighting research among the homeless population in Amsterdam, which was conducted by @DrEgeneraal, @DanielavSanten, @marjoleinbooij, Sophie Campman, Mariken van der Lubben, and colleagues.
1/5 Hi everyone, Elke here! @epi_elks This year @GGDAmsID has worked hard on various #research studies on #COVID19. It is my pleasure to showcase some of these studies this week! 📈
To wrap up the year we will be focusing this week on our #COVID19 research🤓
📄What have we done so far?
📉The data: from virological data🧪to longitudinal cohort studies 👥
📅 Our plans for 2022! 🧐 ...so stayed tuned!
This week will be curated by @epi_elks
1/6🧵So far this week, we have looked at rates and risk factors of testing positive for #SARSCoV2 in Amsterdam. But what actually happens to those with #COVID19 over time? 🤒🤧
In this time and age, how do HIV-positive men who have sex with men experience living with HIV? 🤔
find some unexpected answers at…..
https://t.co/lXG2a2qYpG
Study by @epi_elks et al @GGDAmsID 👇
🗓 After 1 year,
2 out of 5 people with symptomatic #COVID19 still experience symptoms
By disease severity:
🤧 1 in 6 with mild disease
&
🛌🏥1 in 2 with moderate-severe/critical disease
(most common: fatigue)
#longCOVID#ReCoVERED
Event-driven #Prep 💊 is highly effective to prevent #HIV, but adherence is key.
In the Amsterdam PrEP study, we observed very high ⬆️adherence to event-driven PrEP, especially around days of possible exposure.
@jiasociety@SchimMaarten
https://t.co/OT4dLany2y
Uptake of #HPV vaccination is very low among girls of Moroccan origin living in Amsterdam. Amina Aljic found out why by interviewing their mothers. See poster nr522 this week @IPVSociety#HPVvaccine@SchimMaarten
New insights into PrEP use, condom use and choice for daily or intermittent use: Vita Jongen defends her PhD thesis on Monday 29 Nov at UvA. https://t.co/8NGviuO4O3
How did the #COVID19 restrictions🏠 affect #PrEP💊 use, sexual healthcare use and STI incidence among MSM in #Amsterdam This question will be answered tomorrow by Feline de la Court (PhD student, GGD Amsterdam) during a spotlight presentation at 🕢15:30 at #NCHIV 2021!
Daily 🗓️ and event-driven #PrEP are both recommended for MSM, but how do MSM use PrEP in real-life?
Great presentation by Vita Jongen at #NCHIV today showing that 4 distinct trajectories📈 of PrEP💊 use were found ranging from infrequent to daily use.
Elizabeth Wahome defends her PhD thesis today 🕖10:00 at #UVA#HIV infection identification and #PrEP💊 eligibility, uptake and
adherence among MSM followed in a HIV vaccine feasibility cohort study in coastal Kenya🇰🇪.
Great work supervised by: @sanders_eduard & Maria Prins
Higher ⬆️ chronic #HBV, #HCV and #HIV prevalence among undocumented migrants and uninsured legal residents in 🇳🇱 than the general Dutch population. Highlighting the importance of #screening in this group
https://t.co/WQaiJZMeII
#EuroTestWeek@DrEGeneraal
@YvanDuijnhoven
Follow us for the latest research on 👇🏾
HIV | Hepatitis | PrEP | COVID-19 | STIs | Harm reduction | Chemsex & more!
🦠💉😷💊📈
From the Public Health Service Amsterdam, ID research & prevention department🇳🇱 🏳️🌈
@GGDAmsterdam#publichealth#scicomm